Neo or Not Neo? Widefield OCT-A Reveals Hidden Neovascularization

• by Julie Rodman, OD, MSc, FAAO

• March 2, 2026

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

• by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

• May 14, 2026

• 2 min

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

• by Andrea Surnit

• April 15, 2026

• 5 min

A clinically interpretable machine learning model for early detection of diabetic retinopathy in multiple community health centers

• by Juncheng Tong, Aifa Tang, Lifang Liu, Luyuan Zhang, Hainan Wang, Mengyuan Qu, Bing Liu

• May 4, 2026